6^th Global Ophthalmologists Annual Meeting

Biography

Kay Rittenhouse has an extensive career in ophthalmic drug research and development, spanning from drug discovery, translational research, clinical development through launch. She has developed drug targets presented on platforms such as small molecules, aptamers, antibodies, and siRNAs. She is a sought after presenter and chair of scientific conferences and forums and has published abstracts, book chapters, and manuscripts for peer reviewed journals. Her drug development expertise includes indications such as glaucoma, retinal diseases such as diabetic retinopathy and AMD, uveitis, and diseases of the ocular surface. She received a Ph.D. in pharmacokinetics from the University of North Carolina at Chapel Hill. Her dissertation research explored the pharmacodynamics of glaucoma drugs and special expertise in ocular microdialysis. She has pharmaceutical industry experience, having worked at Alcon Laboratories, Bausch and Lomb, and Pfizer.

Research Interest

Glaucoma, retinal diseases such as diabetic retinopathy